Key result
Insulin resistance linked to ~8-fold greater LVH risk in Black sub-Saharan African hypertensive patients.
Why the study?
Conflicting information exists regarding the association between insulin resistance and left ventricular hypertrophy.
Is insulin resistance associated with left ventricular hypertrophy in asymptomatic Black sub-Saharan African hypertensive patients?
Case-Control (n=220)
No
Is insulin resistance associated with left ventricular hypertrophy in asymptomatic Black sub-Saharan African hypertensive patients?
Obesity and insulin resistance are strong independent predictors of left ventricular hypertrophy in Black sub-Saharan African patients with essential hypertension.
May inform LVH risk evaluation in Black African hypertensives; hypothesis-generating and requires prospective confirmation.
Background: Conflicting information exists regarding the association between insulin resistance (IR) and left ventricular hypertrophy (LVH).We described the associations between obesity, fasting insulinemia, homeostasis model assessment of insulin resistance (HOMA-IR), and LVH in Black patients with essential hypertension. Methods: A case-control study was conducted at the Centre Médical de Kinshasa (CMK), the Democratic Republic of the Congo, between January and December 2019. Cases and controls were hypertensive patients with and without LVH, respectively. The relationships between obesity indices, physical inactivity, glucose metabolism and lipid disorder parameters, and LVH were assessed using linear and logistic regression analyses in simple and univariate exploratory analyses, respectively. When differences were observed between LVH and independent variables, the effects of potential confounders were studied through the use of multiple linear regression and in conditional logistic regression in multivariate analyses. The coefficients of determination (R 2 ), adjusted odds ratios (aORs), and their 95% confidence intervals (95% CIs) were calculated to determine associations between LVH and the independent variables. Results: Eighty-eight LVH cases (52 men) were compared against 132 controls (81 men). Variation in left ventricular mass (LVM) could be predicted by the following variables: age (19%), duration of hypertension (31.3%), body mass index (BMI, 44.4%), waist circumference (WC, 42.5%), glycemia (20%), insulinemia (44.8%), and HOMA-IR (43.7%). Hypertension duration, BMI, insulinemia, and HOMA-IR explained 68.3% of LVM variability in the multiple linear regression analysis. In the logistic regression model, obesity increased the risk of LVH by 3-fold [aOR: 2.8; 95% CI (1.06–7.4); p = 0.038], and IR increased the risk of LVH by 8-fold [aOR: 8.4; 95: (3.7–15.7); p < 0.001]. Conclusion: Obesity and IR appear to be the primary predictors of LVH in Black sub-Saharan African hypertensive patients. The comprehensive management of cardiovascular risk factors should be emphasized, with particular attention paid to obesity and IR. A prospective population-based study of Black sub-Saharan individuals that includes the use of serial imaging remains essential to better understand subclinical LV deterioration over time and to confirm the role played by IR in Black sub-Saharan individuals with hypertension.
No takes yet. Share an insight, caveat, or question.
Phanzu et al. (2020) conducted a case-control in Essential hypertension (n=220). Insulin resistance vs. No insulin resistance was evaluated on Left ventricular hypertrophy (aOR 8.4, 95% CI 3.7-15.7, p=<0.001). Insulin resistance increased the risk of left ventricular hypertrophy by 8-fold (aOR 8.4) in Black sub-Saharan African hypertensive patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: